Doug Lankler

(Mr. Douglas Lankler)

Currently holds a position at Pfizer Inc

Positions
Position Company Period
Executive Vice President, General Counsel Pfizer Inc Feb. 1, 2014 -
Executive Vice President, General Counsel, Corporate Secretary Pfizer Inc Jan. 1, 2014 - Feb. 1, 2014
Executive Vice President, General Counsel Pfizer Inc Dec. 1, 2013 - Jan. 1, 2014
Executive Vice President, Chief Compliance and Risk Officer Pfizer Inc Feb. 1, 2011 - Dec. 1, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-05-13 2022-05-12
US Pfizer Inc (PFE)
S Sale
38,273 -32.7%
49.41
1,891,069 USD 		38,273 -32.7% 49.41 1,891,069 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
6,400 -8.8%
54.30
347,520 USD 		6,400 -8.8% 54.30 347,520 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
5,856 -7.5%
54.31
318,039 USD 		5,856 -7.5% 54.31 318,039 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
5,765 -6.8%
54.40
313,616 USD 		5,765 -6.8% 54.40 313,616 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
5,203 -5.8%
54.17
281,847 USD 		5,203 -5.8% 54.17 281,847 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
4,500 -4.8%
54.55
245,475 USD 		4,500 -4.8% 54.55 245,475 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
4,200 -4.3%
54.50
228,900 USD 		4,200 -4.3% 54.50 228,900 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
2,736 -2.7%
54.39
148,811 USD 		2,736 -2.7% 54.39 148,811 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,677 -1.6%
54.46
91,329 USD 		1,677 -1.6% 54.46 91,329 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,497 -1.4%
54.47
81,542 USD 		1,497 -1.4% 54.47 81,542 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,133 -1.1%
54.26
61,477 USD 		1,133 -1.1% 54.26 61,477 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
909 -0.9%
54.45
49,495 USD 		909 -0.9% 54.45 49,495 USD
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
124 -0.1%
54.32
6,736 USD 		124 -0.1% 54.32 6,736 USD
2020-05-01 2020-04-29
US Pfizer Inc (PFE)
S Sale
57,099 -42.2%
37.83
2,160,055 USD 		57,099 -42.2% 37.83 2,160,055 USD
2020-05-01 2020-04-29
US Pfizer Inc (PFE)
S Sale
7,901 -5.5%
38.01
300,317 USD 		7,901 -5.5% 38.01 300,317 USD
2019-02-01 2019-02-01
US Pfizer Inc (PFE)
S Sale
5,000 -11.1%
42.75
213,750 USD 		5,000 -11.1% 42.75 213,750 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
17,099 -27.5%
41.19
704,308 USD 		17,099 -27.5% 41.19 704,308 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
9,136 -12.8%
41.20
376,403 USD 		9,136 -12.8% 41.20 376,403 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
6,000 -7.8%
41.18
247,080 USD 		6,000 -7.8% 41.18 247,080 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
2,100 -2.6%
41.16
86,436 USD 		2,100 -2.6% 41.16 86,436 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
1,800 -2.2%
41.15
74,070 USD 		1,800 -2.2% 41.15 74,070 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
1,500 -1.8%
41.17
61,755 USD 		1,500 -1.8% 41.17 61,755 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
900 -1.1%
41.22
37,098 USD 		900 -1.1% 41.22 37,098 USD
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
265 -0.3%
41.21
10,921 USD 		265 -0.3% 41.21 10,921 USD